Skip to main content
Equibles
MEDP logo

MEDP · Medpace Holdings, Inc. · Analyst Estimates

Track MEDP — free

Use MEDP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MEDP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$692.68 +18.89 (+2.80%) Q3 2026 earnings call transcript
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$18.85B
Shares
27.97M
Volume · Oct 28 301.64K Avg daily vol (3M) 265.06K

Analyst Estimates

Compare analyst forecasts for Medpace Holdings, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-28 02:40 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
18.11
18.36
18.92
11
17.72
17.70
17.70
17.70
0
0
2
2
Revenue
USD
Publication date not stated
2.84B
2.85B
2.87B
13
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
19.30
19.85
20.35
11
19.32
19.31
19.31
19.31
1
1
1
1
Revenue
USD
Publication date not stated
2.86B
3.02B
3.08B
13
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
4.77
4.88
5.06
9
4.69
4.70
4.70
4.70
1
1
1
1
Revenue
USD
Publication date not stated
710.00M
718.40M
725.04M
11
 — — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
4.50
4.66
4.91
7
4.59
4.61
4.61
4.61
2
2
2
2
Revenue
USD
Publication date not stated
713.67M
726.89M
742.22M
8
 — — — — — — — —
Key facts CIK 1668397 CUSIP 58506Q109 13F (30d) 190 filings 181 filers Visit website Investor relations